Lifestyle Modification and Incretin-Based Therapy for Obesity
JAMA · 23.06.2026 · 335 (24) · 2160
DOI: 10.1001/jama.2026.4106 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 23.06.2026. Verfasst von Robert F Kushner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This JAMA Insights discusses strategies for lifestyle modifications and managing adverse effects for individuals with obesity receiving incretin-based therapies for weight loss.
Autor:innen und Institutionen
- Departments of Medicine and Medical Education, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Johns Hopkins School of Nursing, Baltimore, Maryland.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Zitieren
APA
Kushner, R. F., Chao, A. M., & Wadden, T. A. (2026). Lifestyle Modification and Incretin-Based Therapy for Obesity. JAMA, 335(24), 2160. https://doi.org/10.1001/jama.2026.4106
Vancouver
Kushner RF, Chao AM, Wadden TA. Lifestyle Modification and Incretin-Based Therapy for Obesity. JAMA. 2026;335(24):2160. doi:10.1001/jama.2026.4106
BibTeX
@article{Kushner2026,
author = {Kushner, Robert F and Chao, Ariana M and Wadden, Thomas A},
title = {Lifestyle Modification and Incretin-Based Therapy for Obesity},
journal = {JAMA},
year = {2026},
volume = {335},
number = {24},
pages = {2160},
doi = {10.1001/jama.2026.4106}
}
EUVIMED